Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.
Pediatr Blood Cancer
; 67(12): e28516, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-32573959
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Neoplasms, Neuroepithelial
/
Antineoplastic Agents, Alkylating
/
Diabetes Insipidus, Neurogenic
/
Rare Diseases
/
Temozolomide
Type of study:
Prognostic_studies
Limits:
Child
/
Humans
/
Male
Language:
En
Journal:
Pediatr Blood Cancer
Year:
2020
Document type:
Article